Document is current

Any future updates will be listed below

Analysis of Fixed-Dose Combination Products Approved by the US Food and Drug Administration, 2010–2015: Implications for Designing a Regulatory Shortcut to New Drug Application

Crossref DOI link: https://doi.org/10.1177/2168479016663263

Published Online: 2017-12-31

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark